HUMANIGEN, INC·4

Mar 14, 4:37 PM ET

Kilcoyne Adrian 4

4 · HUMANIGEN, INC · Filed Mar 14, 2022

Insider Transaction Report

Form 4
Period: 2022-03-08
Kilcoyne Adrian
Chief Medical Officer
Transactions
  • Purchase

    Common Stock

    2022-03-08$2.53/sh+7,000$17,7107,000 total
  • Purchase

    Common Stock

    2022-03-09$2.78/sh+5,000$13,90012,000 total
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.52 to $2.53, inclusive. The reporting person undertakes to provide upon request to the issuer, the Securities and Exchange Commission or any security holder of the issuer full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.75 to $2.80, inclusive. The reporting person undertakes to provide upon request to the issuer, the Securities and Exchange Commission or any security holder of the issuer full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Documents

2 files
  • 4
    marketforms-55788.xmlPrimary

    PRIMARY DOCUMENT

  • EX-24

    POA DOCUMENT